awards grant
- A hPSC-based multiplex platform to interrogate diabetogenic interactions of T2D-associated genes in human pancreatic beta-cells.
- Targeting DUSP26 to enhance beta cell function and viability for the treatment of type 2 diabetes
- Targeting glucocorticoid circadian rhythmicity for β-cell regeneration: neuroendocrine and intracellular pathways.